Your shopping cart is currently empty

Fostroxacitabine bralpamide (MIV-818) is an orally active, Troxacitabine-based nucleotide prodrug with anticancer effects.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | Inquiry | Inquiry |
| Description | Fostroxacitabine bralpamide (MIV-818) is an orally active, Troxacitabine-based nucleotide prodrug with anticancer effects. |
| In vitro | Fostroxacitabine bralpamide (MIV-818) undergoes significant metabolism by human hepatocytes, resulting in elevated concentrations of the chain-terminating nucleotide tri-phosphate in the liver. This tri-phosphate incorporates into DNA during the replication process, culminating in DNA double-strand breaks, eliciting DNA damage responses, and inducing cytotoxicity[1]. |
| Synonyms | MIV-818 |
| Molecular Weight | 589.37 |
| Formula | C22H30BrN4O8P |
| Cas No. | 2129993-56-0 |
| Smiles | CCC[C@H](C)OC(=O)[C@H](C)NP(=O)(OC[C@H]1OC[C@H](O1)n1ccc(N)nc1=O)Oc1ccc(Br)cc1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.